Saturday, July 11, 2026

pharma · Complement-mediated Hemolytic Diseases

Nanjing Chia-tai Tianqing

Nanjing Chia-tai Tianqing trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Trials

Nanjing Chia-tai Tianqing clinical trials

Registry index of 1 ClinicalTrials.gov studies linked to Nanjing Chia-tai Tianqing programs — each row shows trial ID, program name, phase, status, and indication.

Nanjing Chia-tai Tianqing trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

1 updates

Latest clinical program signals indexed for Nanjing Chia-tai Tianqing.

  1. NTQ5082 capsule — Phase 1

    Clinical update

Trial registry

1 studies